Skip to main content
Premium Trial:

Request an Annual Quote

Arbitrator Allows Gen-Probe to Join Digene and Roche License Dispute

NEW YORK (GenomeWeb News) — An arbitration panel overseeing a legal skirmish between Digene and Roche has allowed Gen-Probe to participate in the proceeding, Digene said today.
 
In the proceeding, Digene hopes to prove that a February 2005 supply and license agreement between Roche and Gen-Probe was an illegal sublicense under a 1990 cross-license agreement, the rights to which are held by Digene and Roche.
The 1990 cross-license agreement was struck between Digene predecessor Life Technologies and Roche predecessor the Pasteur Institute.
 
Digene said it filed for the arbitration in December 2006, saying that Roche had transferred to Gen-Probe human papillomavirus products under “the guise of a supply and purchase agreement,” Digene said.  
 
The American Arbitration Association’s International Center for Dispute Resolution in New York is arbitrating the case.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.